NCT00650208View on ClinicalTrials.gov

Fasting Study of Lamotrigine Tablets 25 mg to Lamictal® Tablets 25 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

August 31, 2004

Study Completion Date

August 31, 2004

Conditions
Healthy
Interventions
DRUG

Lamotrigine Tablets 25 mg

2x25mg, single dose fasting

DRUG

Lamictal® Tablets 25 mg

2x25mg, single dose fasting

Trial Locations (1)

26505

Kendle International Inc., Morgantown

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY